The Filing Desk

Innoviva vs Zai Lab

Innoviva INVA · Zai Lab ZLAB · Pharmaceuticals

Zai Lab reported revenue of $460 million in fiscal 2025, about the same as Innoviva's $411 million in fiscal 2025. Innoviva's revenue grew 14.7% in its latest year, and Zai Lab's grew 15.3%. Innoviva had an operating margin of 39.8%, against -49.9% at Zai Lab. Free cash flow was $196 million at Innoviva and −$159 million at Zai Lab.

Side by side

InnovivaZai Lab
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$411M$460M
Revenue growth14.7%15.3%
Revenue growth a year, last 5 years4.1%56.5%
Gross margin74.8%58.6%
Operating margin39.8%−49.9%
Net margin65.9%−38.1%
Free cash flow$196M−$159M
Free cash flow margin47.6%−34.5%
Return on capital17.9%—
Net debt to EBITDA——
Dividends and buybacks$4M$0M
Change in diluted share count14.2%10.7%
Last close$18.41$21.92
P/E at the last close9.2×—
Insider trades, last 12 months—bought $65,804, sold $11.1 million
Piotroski F-score6 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
InnovivaZai Lab
Operating margin
Percent of revenue
InnovivaZai Lab
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InnovivaZai Lab

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Innoviva and Zai Lab pages.